Inventor · Wallingford, CT, US

Kyle E. Parcella

24Patents
5h-index
67Co-inventors
68Inventor score

Filing activity: Nov 2, 2006 → Oct 22, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8198449B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 19 Active
US7994171B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 16 Active
US8048887B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 16 Active
US8536338B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 6 Active
US8293909B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 6 Active
US8431695B2 Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases Human Necessities 4 Active
US8309558B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 4 Active
US9738653B2 Fused furans for the treatment of hepatitis C Chemistry; Metallurgy 3 Active
US8143393B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Human Necessities 3 Active
US8133995B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Human Necessities 2 Active
US8129379B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Human Necessities 2 Active
US10745382B2 Compounds useful as immunomodulators Emerging Cross-Sectional Technologies 2 Active
US8722688B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 2 Active
US8829185B2 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Human Necessities 2 Active
US8148382B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 2 Active
US8962651B2 Compounds for the treatment of hepatitis C Chemistry; Metallurgy 1 Active
US10214534B2 Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C Chemistry; Metallurgy 0 Active
US9249152B2 Cyano containing azabenzofuran compounds for the treatment of hepatitis C Chemistry; Metallurgy 0 Active
US9938271B2 Inhibitors of human immunodeficiency virus replication Chemistry; Metallurgy 0 Active
US11505543B2 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication Chemistry; Metallurgy 0 Active
US9957278B2 Furopyridine compounds for the treatment of hepatitis C Chemistry; Metallurgy 0 Active
US10351546B2 Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication Human Necessities 0 Active
US11541055B2 Inhibitors of human immunodeficiency virus replication Chemistry; Metallurgy 0 Active
US10189816B2 Substituted pyridines as inhibitors of human immunodeficiency virus replication Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.